Singapore COVID-19 data cross-validation by the Gaidai reliability method

Author:

Gaidai Oleg,Yakimov Vladimir,Sun Jiayao,van Loon Eric-Jan

Abstract

AbstractNovel coronavirus infection (COVID-19) has exserted certain burden on global public health, spreading around the world with reportedly low mortality and morbidity. This study advocates novel bio and health system reliability approach, especially suitable for multi-regional environmental and health systems. Advocated spatiotemporal method has been cross-validated, versus well established bivariate Weibull method, based on available raw clinical dataset. The purpose of this study was to assess risks of excessive coronavirus death rates, that may occur within any given time horizon, and in any region or district of interest. This study aims at benchmarking of the novel Gaidai bio-reliability method, allowing accurate assessment of national public health system risks, for the years to come. Novel bio-system reliability approach is particularly suitable for multi-regional environmental and health systems, monitored for a sufficiently representative period of time. In case when underlying bio-system is stationary, or the underlying trend is known, long-term future death rate risk assessment can be done, and confidence intervals can be generated. Advocated methodology may to be useful for a wide variety of public health applications, thus, it is not limited to the example, considered here.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3